Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

556 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.
Bladé J, Rosiñol L, Sureda A, Ribera JM, Díaz-Mediavilla J, García-Laraña J, Mateos MV, Palomera L, Fernández-Calvo J, Martí JM, Giraldo P, Carbonell F, Callís M, Trujillo J, Gardella S, Moro MJ, Barez A, Soler A, Font L, Fontanillas M, San Miguel J; Programa para el Estudio de la Terapéutica en Hemopatía Maligna (PETHEMA). Bladé J, et al. Among authors: soler a. Blood. 2005 Dec 1;106(12):3755-9. doi: 10.1182/blood-2005-03-1301. Epub 2005 Aug 16. Blood. 2005. PMID: 16105975 Free article. Clinical Trial.
Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma.
Granell M, Senín A, Barata A, Cibeira MT, Gironella M, López-Pardo J, Motlló C, Garcia-Guiñón A, Ben-Azaiz R, Abella E, Soler A, Canet M, Martí JM, Martino R, Sierra J, de Larrea CF, Oriol A, Rosiñol L; Group for the Study of Myeloma and Amyloidosis of Catalonia (GEMMAC). Granell M, et al. Among authors: soler a. Bone Marrow Transplant. 2021 Dec;56(12):2904-2910. doi: 10.1038/s41409-021-01429-0. Epub 2021 Aug 17. Bone Marrow Transplant. 2021. PMID: 34404917
A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results.
López-Guillermo A, Canales MÁ, Dlouhy I, Mercadal S, Briones J, Martín García-Sancho A, Sancho JM, Moraleda JM, Terol MJ, Salar A, Palomera L, Gardella S, Jarque I, Ferrer S, Bargay J, López A, Panizo C, Muntañola A, Montalbán C, Conde E, Hernández MT, Soler A, García Marco JA, Deben G, Marín J, Tomás JF; PETHEMA/GELTAMO/GELCAB Spanish Intergroup. López-Guillermo A, et al. Among authors: soler a. Leuk Lymphoma. 2022 Jan;63(1):93-100. doi: 10.1080/10428194.2021.1971216. Epub 2021 Aug 30. Leuk Lymphoma. 2022. PMID: 34459702 Clinical Trial.
Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real-world setting.
Alegre A, Gironella M, Escalante F, Bergua JM, Martínez-Chamorro C, López A, González E, Bárez A, Somolinos N, Persona EP, Cabrera AS, Soler A, Rodríguez BI, López JM, González Y, Giménez VC, Sampol A, Muñoz C, Vilanova D, Durán M, Fernández de Larrea C; Spanish Myeloma Group (GEM_PETHEMA). Alegre A, et al. Among authors: soler a. Hemasphere. 2024 Jul 4;8(7):e81. doi: 10.1002/hem3.81. eCollection 2024 Jul. Hemasphere. 2024. PMID: 38974896 Free PMC article.
Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapy.
Pérez R, Durán MS, Mayans J, Soler A, Castillo I, Jurado M, Ribas P, Menchaca Echevarria MC, Hernandez MT, Lopez Garcia-Carreño MD, Echeveste Gutierrez A, Bailen Garcia A, Lopez S, Baquero J, Ramirez G. Pérez R, et al. Among authors: soler a. Eur J Haematol. 2016 Apr;96(4):417-24. doi: 10.1111/ejh.12611. Epub 2015 Nov 1. Eur J Haematol. 2016. PMID: 26190662
Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group.
Muntañola A, Baumann T, Caballero AC, Sánchez-González B, Mercadal S, Escoda L, Soler A, Iserte L, Canet M, Villalobos MT, Magnano L, Sorigué M, García O, Salar A, López-Guillermo A, Sancho JM. Muntañola A, et al. Among authors: soler a. Ann Hematol. 2020 Jul;99(7):1627-1634. doi: 10.1007/s00277-020-04101-7. Epub 2020 May 25. Ann Hematol. 2020. PMID: 32451707
Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy.
Vicente EP, Cuellar-García C, Martinez M, Soler A, Mora A, Bosch R, Brunet S, Briones J, García I, Esquirol A, Granell M, Saavedra S, Nomdedeu J, Sierra J, Martino R, Moreno C. Vicente EP, et al. Among authors: soler a. Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):737-742. doi: 10.1016/j.clml.2018.06.023. Epub 2018 Jun 27. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30017595
Epidemiology of aplastic anemia: a prospective multicenter study.
Montané E, Ibáñez L, Vidal X, Ballarín E, Puig R, García N, Laporte JR; Catalan Group for Study of Agranulocytosis and Aplastic Anemia. Montané E, et al. Haematologica. 2008 Apr;93(4):518-23. doi: 10.3324/haematol.12020. Epub 2008 Mar 5. Haematologica. 2008. PMID: 18322256 Free article.
Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale.
Bonanad S, De la Rubia J, Gironella M, Pérez Persona E, González B, Fernández Lago C, Arnan M, Zudaire M, Hernández Rivas JA, Soler A, Marrero C, Olivier C, Altés A, Valcárcel D, Hernández MT, Oiartzabal I, Fernández Ordoño R, Arnao M, Esquerra A, Sarrá J, González-Barca E, González J, Calvo X, Nomdedeu M, García Guiñón A, Ramírez Payer A, Casado A, López S, Durán M, Marcos M, Cruz-Jentoft AJ; GAH Group. Bonanad S, et al. Among authors: soler a. J Geriatr Oncol. 2015 Sep;6(5):353-61. doi: 10.1016/j.jgo.2015.03.003. Epub 2015 Jun 29. J Geriatr Oncol. 2015. PMID: 26139300
556 results